Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP568060.RA_63MFaBufUF9Gff2wRSVxqNrAhEsjR-v1Iet5wmWxwk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP568060.RA_63MFaBufUF9Gff2wRSVxqNrAhEsjR-v1Iet5wmWxwk130_assertion type Assertion NP568060.RA_63MFaBufUF9Gff2wRSVxqNrAhEsjR-v1Iet5wmWxwk130_head.
- NP568060.RA_63MFaBufUF9Gff2wRSVxqNrAhEsjR-v1Iet5wmWxwk130_assertion description "[Here, we used low-density arrays, quantitative PCR, and western blotting to determine how HER2 signaling inhibition with lapatinib or PI3K inhibitors affects the expression of genes involved in breast cancer metastatic spread and overall prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP568060.RA_63MFaBufUF9Gff2wRSVxqNrAhEsjR-v1Iet5wmWxwk130_provenance.
- NP568060.RA_63MFaBufUF9Gff2wRSVxqNrAhEsjR-v1Iet5wmWxwk130_assertion evidence source_evidence_literature NP568060.RA_63MFaBufUF9Gff2wRSVxqNrAhEsjR-v1Iet5wmWxwk130_provenance.
- NP568060.RA_63MFaBufUF9Gff2wRSVxqNrAhEsjR-v1Iet5wmWxwk130_assertion SIO_000772 20126311 NP568060.RA_63MFaBufUF9Gff2wRSVxqNrAhEsjR-v1Iet5wmWxwk130_provenance.
- NP568060.RA_63MFaBufUF9Gff2wRSVxqNrAhEsjR-v1Iet5wmWxwk130_assertion wasDerivedFrom befree-20140225 NP568060.RA_63MFaBufUF9Gff2wRSVxqNrAhEsjR-v1Iet5wmWxwk130_provenance.
- NP568060.RA_63MFaBufUF9Gff2wRSVxqNrAhEsjR-v1Iet5wmWxwk130_assertion wasGeneratedBy ECO_0000203 NP568060.RA_63MFaBufUF9Gff2wRSVxqNrAhEsjR-v1Iet5wmWxwk130_provenance.